Sarfaraz Dhanji
Family Medicine · Jacksonville, FLNPI 1720271703
Payments from drug & device makers
Across 770 payments — averaging $75.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$49K
- Novo Nordisk$1K
- GSK$1K
- AbbVie$1K
- AstraZeneca$805
- Amarin Pharma, Inc.$603
- plus $5K from 45 others
What the payments were for
- Speaking & faculty fees$38,60066%
- Travel & lodging$6,74912%
- Food & beverage$12,95722%
- Education$1540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$58,460 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 36 | $52,655 |
| OzempicSemaglutide | 35 | $32,585 |
| FarxigaDapagliflozin Propanediol | 18 | $20,837 |
| Repatha SureclickEvolocumab | 22 | $13,546 |
| Clonidine | 11 | $2,034 |
| Testosterone Cypionate | 18 | $1,242 |
| Liothyronine Sodium | 14 | $977 |
| Atorvastatin Calcium | 93 | $916 |
| Olanzapine | 22 | $760 |
| Celecoxib | 11 | $713 |
| Gabapentin | 33 | $656 |
| Metoprolol Succinate | 36 | $640 |
| Tamsulosin Hcl | 24 | $570 |
| Levothyroxine Sodium | 41 | $507 |
| Rosuvastatin Calcium | 60 | $490 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Olanzapine | $390 | $53,41558 claims |
| Novo NordiskOzempic | $1,236 | $32,58535 claims |
| AstraZenecaFarxiga | $805 | $20,83718 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $13 | $50741 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Jacksonville
- Jeffry JacqmeinJacksonville$8.7M
- Herman DowneyJacksonville$4.1M
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.